GENEVA, Aug. 31 -- BETA PHARMA, INC. filed a patent application (US2026/015781) for “1,5-NAPHTHYRIDINE PROTAC DERIVATIVES AS KRAS ONCOPROTEIN INHIBITORS”. With publication no. WO/2026/178202, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4375
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....